NCT04305938View on ClinicalTrials.gov

A Human Clinical Study to Collect Calibration and Performance Data for the RBA-1 and KBS-1

UnknownOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Calibration and Validation of Analyte Testing System
Interventions
DIAGNOSTIC_TEST

Minimally invasive and non-invasive blood analyte measurement

Rapid point-of-care minimally invasive blood analyzer consisting of a spectrometer and a computer loaded with Kaligia software that controls the data acquisition and signal processing to interpret blood analyte measurement.

Trial Locations (1)

33606

Tampa General Hospital, Tampa

Sponsors
All Listed Sponsors
lead

Kaligia Biosciences, LLC

INDUSTRY